This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
EBE, EFPIA and IFPMA launch position paper on switching decisions regarding biosimilars
Read more
Long-term safety and efficacy extension study data of Alprolix® published
Read more
Biologics and biosimilars in IBD
Read more
Two out of three patients report being involved in decisions about IPF treatment
Read more
First biosimilar mAb in oncology is granted EU marketing authorisation
Read more
Broadened marketing authorisation for Darzalex in multiple myeloma recommended
Read more
Heart rhythm charity raises alarm at variable quality of care for patients at risk of sudden cardiac arrest
Read more
Study finds hospital tablet computers cut nurse time by up to 30%
Read more
SMC accepts six new medicines for routine use in NHS Scotland
Read more
Philips and Diagnostics Development win EU ‘Horizon Prize – Better Use of Antibiotics’
Read more
Innovative preoperative assessment questionnaire wins regional accolade
Read more
Sobi obtains approval from the European Commission for new dosing frequency of Orfadin
Read more
Biosimilars create opportunities for sustainable cancer care
Read more
Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review
Read more
Specialist service to share expertise in rare pregnancy complication across Europe
Read more
New guidance on patient consent for anaesthesia
Read more
Next generation Proxima™ launched – delivering bedside blood gas and glucose analysis
Read more
Page 137 of 200
« First
«
...
10
20
30
...
135
136
137
138
139
...
150
160
170
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: